Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pro-inflammatory and oxidative stress pathway proteins encompass a diverse group of molecular entities, including cytokines, enzymes, and transcription factors, that coordinate the cellular response to injury and environmental stressors. Key pro-inflammatory mediators such as Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-6 (IL-6) are regulated by the Nuclear Factor-kappa B (NF-kappaB) signaling pathway, which is a central driver of chronic inflammation (Source: StatPearls, NCBI). Simultaneously, oxidative stress proteins like NADPH oxidase (NOX) generate reactive oxygen species (ROS), while the Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway serves as the primary defense mechanism by upregulating antioxidant enzymes like Superoxide Dismutase (SOD) (Source: UniProt, PubMed). The interplay between these pathways is critical, as ROS can act as secondary messengers to amplify inflammatory signaling, contributing to the pathogenesis of diseases such as atherosclerosis, Alzheimer's disease, and rheumatoid arthritis (Source: Nature Reviews Drug Discovery). Pharmacological intervention typically targets specific nodes within these pathways, such as using monoclonal antibodies to neutralize cytokines or small molecules to activate antioxidant defenses (Source: PubChem). Dysregulation of these proteins often leads to a self-perpetuating cycle of tissue damage and immune activation. Understanding the specific protein interactions within these pathways is essential for developing targeted therapies that minimize off-target effects. These proteins are also vital for normal physiological processes, such as wound healing and pathogen defense, making their modulation a delicate balance.
Inhibition of pro-inflammatory cytokine signaling, inhibition of cyclooxygenase enzymes, or activation of the Nrf2-mediated antioxidant response.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-inflammatory and oxidative stress pathway proteins.